Stock listing

BOATS:ALEC Alector, Inc. Stock

US listing (BOATS) of Alector, Inc. · home listing NASDAQ:ALEC

Follow Alector, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:ALEC

$2.34 USD -0.23 (-9.1%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ALEC

Past year +94.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$2.27 – $2.48 USDNov 20, 2026
Volume
1.95M sharesNov 20, 2026
Market cap
$347.6M USDAt the close on Nov 20, 2026 · price × 148.9M shares outstanding
52-week range
$1.09 – $2.84 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$6.77M USDMedian day 1.46M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Alector, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ALEC · Home$2.335 USD-0.235 (-9.1%)1,953,176$2.28$2.48$2.27$2.57Close on Nov 20, 2026
Frankfurt:0Z2€2.054 EUR-0.248 (-10.8%)—€2.054€2.054€2.054€2.302Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ALEC · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$2.335-0.235-9.1%$2.28$2.48$2.271,953,176
$2.57+0.01+0.4%$2.57$2.74$2.512,133,508
$2.56-0.01-0.4%$2.57$2.61$2.501,268,972
$2.57+0.03+1.2%$2.54$2.655$2.5152,769,779
$2.54+0.09+3.7%$2.59$2.59$2.301,799,131
$2.45-0.18-6.8%$2.66$2.66$2.391,871,735
$2.63+0.10+4.0%$2.55$2.84$2.543,476,459
$2.53+0.07+2.8%$2.40$2.64$2.3853,258,445
$2.46+0.17+7.4%$2.29$2.555$2.282,336,637
$2.29+0.20+9.6%$2.18$2.31$2.0851,020,180
$2.09-0.19-8.3%$2.27$2.28$2.021,272,552
$2.28+0.23+11.2%$2.14$2.295$2.081,477,964
$2.05-0.10-4.7%$2.17$2.245$2.031,429,027
$2.15-0.06-2.7%$2.20$2.23$2.09952,460
$2.21-0.03-1.3%$2.20$2.25$2.091,110,898
$2.24-0.01-0.4%$2.25$2.32$2.201,460,699
$2.25+0.15+7.1%$2.08$2.26$2.051,910,158
$2.10+0.27+14.8%$1.82$2.12$1.824,569,623
$1.830.000.0%$1.85$1.94$1.792,659,359
$1.830.000.0%$1.81$1.84$1.721,410,707
$1.83-0.04-2.1%$1.86$1.88$1.741,479,754
$1.87-0.10-5.1%$1.97$2.00$1.851,114,345
$1.97+0.02+1.0%$1.96$2.04$1.9152,021,249
$1.95+0.11+6.0%$1.85$1.99$1.7652,367,825
$1.84-0.07-3.7%$2.18$2.18$1.795,157,884
$1.91+0.03+1.6%$1.92$1.95$1.851,630,377
$1.88+0.01+0.5%$1.84$1.919$1.822,912,375
$1.87-0.21-10.1%$2.07$2.08$1.7752,843,592
$2.080.000.0%$2.08$2.14$2.021,630,342
$2.08+0.06+3.0%$2.01$2.145$2.003,118,490
$2.02+0.10+5.2%$1.90$2.06$1.886,453,307
$1.92+0.11+6.1%$1.78$1.92$1.733,972,727
$1.81-0.18-9.0%$2.08$2.23$1.7510,177,270
$1.99+0.18+9.9%$2.725$2.73$1.9689,983,688
$1.81-0.05-2.7%$1.89$1.965$1.801,170,910
$1.86+0.01+0.5%$1.82$1.91$1.805774,594
$1.85-0.02-1.1%$1.88$1.949$1.83792,697
$1.87-0.05-2.6%$1.95$1.95$1.86960,739
$1.92-0.03-1.5%$1.92$1.955$1.86713,343
$1.95+0.03+1.6%$1.92$2.05$1.901,024,565
$1.92-0.10-5.0%$2.02$2.05$1.905849,547
$2.02+0.01+0.5%$2.00$2.02$1.951,182,749
$2.01+0.08+4.1%$1.97$2.035$1.931,464,201
$1.93+0.02+1.0%$1.90$1.945$1.851,281,187
$1.91+0.06+3.2%$1.85$1.91$1.792,119,032
$1.85-0.075-3.9%$1.96$1.97$1.83931,237
$1.925-0.11-5.4%$2.06$2.06$1.91622,263
$2.035-0.175-7.9%$2.19$2.209$1.985715,905
$2.21+0.07+3.3%$2.15$2.225$2.0952,467,755
$2.140.000.0%$2.17$2.22$2.024,699,046
$2.14-0.13-5.7%$2.22$2.24$2.003,781,817
$2.27-0.20-8.1%$2.47$2.47$2.25505,801
$2.47+0.01+0.4%$2.38$2.61$2.33916,854
$2.46-0.05-2.0%$2.52$2.575$2.44496,601
$2.51-0.21-7.7%$2.70$2.75$2.4352,792,296
$2.72+0.32+13.3%$2.40$2.76$2.401,672,778
$2.40+0.14+6.2%$2.24$2.486$2.22482,393
$2.26-0.08-3.4%$2.32$2.35$2.23610,059
$2.34-0.05-2.1%$2.39$2.44$2.315542,221
$2.39-0.07-2.8%$2.44$2.50$2.39706,964
$2.46+0.10+4.2%$2.38$2.515$2.26996,494
$2.36+0.06+2.6%$2.32$2.455$2.28558,276
$2.30-0.06-2.5%$2.36$2.465$2.29738,144
$2.36+0.10+4.4%$2.28$2.37$2.20728,094
$2.26-0.17-7.0%$2.40$2.46$2.185662,589
Ticker
BOATS:ALEC
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
BOATS
Currency
USD

What changed lately

Latest news

All Alector, Inc. news

Alector, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
11 in the last 12 months · 129 in all · newest Nov 5, 2026 · oldest 2019
Calls
5 calls with a replay · 5 with a transcript · latest Aug 7, 2025
Decks
4 decks · latest Oct 13, 2026

Where Alector, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ALEC · Home listingNASDAQUnited StatesUSD
Tradegate:0Z2TradegateGermanyEUR
LS Exchange:A2PCBMLS ExchangeGermanyEUR
gettex:0Z2gettexGermanyEUR
Lang & Schwarz:A2PCBMLang & SchwarzGermanyEUR
BOATS:ALEC · This pageBOATSUnited StatesUSD
Dusseldorf:0Z2DusseldorfGermanyEUR
Frankfurt:0Z2FrankfurtGermanyEUR
Hamburg:0Z2HamburgGermanyEUR
Munich:0Z2MunichGermanyEUR
Stuttgart:0Z2StuttgartGermanyEUR

Valuation

P/E 8.4× against a median of 17.2×: the lowest of 3 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$208.9M USD
P/E
8.4×
EV/sales
1.2×
EV/EBITDA
4.9×
Price/book
3.0×
Gross margin
Not reported
Operating margin
20.2%
Net margin
23.9%
Debt to equity
0.0×
Beta vs S&P 500
1.72

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Alector, Inc. · NASDAQ:ALECUS$347.6MUS$208.9M8.4×1.2×4.9×3.0×23.9%0.0×1.72
Puma Biotechnology Inc · NASDAQ:PBYIUS$364.5MUS$255.9M15.3×1.1×5.8×2.5×10.3%0.0×0.88
PureTech Health PLC · LSE:PRTCUS$364.3MUS$160.3Mn/a34.4×n/a0.9×n/a0.1×n/a
Lumosa Therapeutics Co Ltd · TPEX:6535US$362.3MUS$343.1Mn/a329×n/a9.7×n/a0.0×n/a
Aspen Neuroscience, Inc. · NASDAQ:ASPEUS$361.2MUS$288.8Mn/an/an/an/an/an/an/a
AbClon, Inc. · KRX:174900US$348.2MUS$321.1Mn/a80.9×n/a8.8×−328.3%0.0×n/a
Gongwin Biopharm Holdings Co., Ltd. · TPEX:6617US$347.3MUS$296.6Mn/a232×n/a4.9×−389.6%0.0×n/a
Onconic Therapeutics, Inc. · KRX:476060US$346.5MUS$299.7M19.1×4.9×n/a5.4×29.5%0.0×n/a
Lyell Immunopharma, Inc. · NASDAQ:LYELUS$339.3MUS$196.5Mn/a13,099×n/a1.8×n/a0.2×1.51
Avacta Group PLC · LSE:AVCTUS$337.8MUS$337.2Mn/a2,281×n/a68.5×n/a5.3×n/a
Inovio Pharmaceuticals, Inc. · NASDAQ:INOUS$329.7MUS$7.56Bn/a25,303×3.4×n/an/an/a0.70
Median of the othersUS$347.8MUS$298.2M17.2×232×4.6×5.2×−159.0%0.0×0.88

Forecasts

3 strong buy · 2 hold · 1 sell · 1 strong sell · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
4.42 USD · Analysts' mean
EPS, year to Dec 2026
0.93 · 6 analysts
Revenue, year to Dec 2026
221M · 7 analysts

Team and board

Officers

OfficerRole
Arnon RosenthalChief Executive Officer, Co-Founder
Neil BerkleyChief Financial Officer and Chief Business Officer
Danielle PasqualoneGeneral Counsel
Hua LongSenior Vice President and Head of Research
Caiyan LiHead of Clinical Development & Data Science
Clare HuntChief People and Places Officer

Board

DirectorRole
Elizabeth GarofaloBoard Member
Errol De SouzaBoard Member
Kristine YaffeBoard Member
Mark AltmeyerBoard Member
Paula HammondBoard Member
Richard H. SchellerBoard Member

Events

Calls

CallWhenStatus
Alector (NASDAQ:ALEC) Q2 2025 Earnings CallThu, Aug 07, 2025 · 4:30 PM ETReplay
Alector (NASDAQ:ALEC) Q4 2024 Earnings CallWed, Feb 26, 2025 · 4:30 PM ETReplay
Alector (NASDAQ:ALEC) Q2 2024 Earnings CallWed, Aug 07, 2024 · 4:30 PM ETReplay
Alector (NASDAQ:ALEC) Q4 2023 Earnings CallTue, Feb 27, 2024 · 4:30 PM ETReplay
Alector (NASDAQ:ALEC) Q2 2023 Earnings CallThu, Aug 03, 2023 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 5, 2026 · After close+9.6%
Q2 2026Aug 6, 2026 · After close−2.7%
Q1 2026May 7, 2026 · After close−13.9%
Q4 2025Mar 3, 2026−2.7%
Q3 2025Nov 6, 2025 · After close−1.5%
Q2 2025Aug 7, 2025 · After close+47.3%
Q1 2025May 8, 2025 · After close+12.5%
Q4 2024Feb 25, 2025 · Before open−0.6%
Q3 2024Nov 6, 2024 · After close+7.6%
Q2 2024Aug 7, 2024 · After close+3.9%
All 20 quarters
QuarterResultsShare move
Q1 2024May 8, 2024 · After close+0.2%
Q4 2023Feb 27, 2024 · After close−0.3%
Q3 2023Nov 7, 2023 · After close−7.3%
Q2 2023Aug 3, 2023 · After close+32.4%
Q1 2023May 4, 2023 · After close+10.3%
Q4 2022Feb 28, 2023 · After close+3.0%
Q3 2022Nov 8, 2022 · After close−19.8%
Q2 2022Aug 4, 2022 · After close+15.3%
Q1 2022May 5, 2022 · After close−6.5%
Q4 2021Feb 24, 2022 · After close−0.9%

Open Events

Decks

DeckKindSlidesDate
Corporate Update (October 2026)Corporate update47 slidesOct 13, 2026
Investor Presentation (October 2026)Investor deck37 slidesOctober 2026
The 7th CNS Drug Delivery Summit (December 2025)Conference24 slidesDec 11, 2025
Technical Presentation (September 2025)Technical55 slidesSeptember 2025

Open Decks

Financings

RaiseDate
Public offering of common stock
Announced: US$75.03M · US$2.05 a share · Morgan Stanley & Co. LLC +1
Dealers: Morgan Stanley & Co. LLC (co-lead), BTIG, LLC (co-lead)
Buyers: TCGX; BVF Partners; ADAR1 Capital Management; Deep Track Capital
Use of proceeds: General corporate purposes, including research, development and manufacturing of product candidates, working capital, capex and possible acquisitions
Oct 16, 2026

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$19.00 a share on Feb 6, 2019.

Price
US$19.00 a share
Shares offered
9,250,000 shares of common stock
Offering size
US$175.8 million
Underwriters' option
Up to 1,387,500 more shares
Underwriters
Morgan Stanley, BofA Merrill Lynch, Cowen, Barclays · In the order on the cover
Shares delivered
On or about Feb 11, 2019

Steps

StepWhen
Draft sent to the SEC in confidenceOct 12, 2018
Filed publiclyJan 7, 2019
Amended twiceNewest Feb 6, 2019
Shares registered with an exchangeJan 31, 2019
Declared effective by the SECFeb 6, 2019
Final prospectus, with the priceFeb 7, 2019

Open IPO · From the cover of the final prospectus (424B4) filed Feb 7, 2019

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue21.0M100.6M97.1M133.6M207.1M21.1M21.2M27.7M3.73M416.0K
Cost of revenue9.66M185.9M8.85M8.47M189.4M156.9M100.5M73.0M29.9M13.7M
Gross profit11.4M-85.4M88.2M133.6M207.1M21.1M21.2M27.7M-26.2M-13.3M
Research and development123.1M185.9M192.1M210.4M189.4M156.9M100.5M73.0M29.9M13.7M
Selling, general and administrative54.0M57.4M56.7M61.0M55.0M59.4M35.1M11.9M6.50M1.87M
Operating income-156.0M-145.0M-151.7M-137.8M-37.4M-195.2M-114.4M-57.3M-32.7M-15.1M
Depreciation and amortization5.72M5.41M5.72M5.71M6.33M5.87M3.77M1.02M680.0K201.0K
EBITDA-150.3M-139.6M-146.0M-132.1M-31.0M-189.3M-110.6M-56.3M-32.0M-14.9M
Interest expense16.3M8.31M00000
Income before tax-142.8M-118.9M-125.1M-130.1M-36.3M-190.2M-105.4M-52.2M-32.5M-15.1M
Income tax168.0K128.0K5.21M3.25M0005.04M00
Net income-142.9M-119.0M-130.4M-133.3M-36.3M-190.2M-105.4M-52.2M-32.5M-15.1M
Earnings per share, basic-1.39-1.23-1.56-1.62-0.45-2.45-1.71-4.62-3.55-1.78
Earnings per share, diluted-1.39-1.23-1.56-1.62-0.45-2.45-1.71-4.62-3.55

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents65.8M33.0M74.6M154.3M329.2M50.0M89.6M65.5M32.5M50.8M
Short-term investments190.2M380.4M474.3M558.5M406.1M363.3M263.4M224.9M
Receivables2.59M7.39M0200.2M218.0K
Inventory1
Current assets266.5M424.8M565.8M726.4M749.7M421.5M357.4M293.2M233.0M51.2M
Property, plant and equipment10.8M17.1M21.9M25.5M27.3M30.2M33.9M10.9M2.83M2.54M
Total assets293.2M468.3M621.8M787.6M814.7M488.3M421.9M308.4M236.1M54.1M
Accounts payable1.69M2.21M3.77M4.19M4.75M3.00M278.0K126.0K1.14M1.15M
Current liabilities69.5M125.1M177.9M93.8M139.6M68.1M62.0M47.9M27.4M1.51M
Long-term debt9.32M9.39M0
Total debt10.4M10.0M043.3M47.6M51.3M48.0M
Total liabilities262.6M341.5M487.7M573.2M513.9M220.7M227.2M195.2M288.1M79.0M
Shareholders' equity30.6M126.8M134.2M214.4M300.7M267.5M194.7M-97.4M-52.0M-24.9M
Shares outstanding110.4M99.1M84.9M82.9M82.0M79.3M69.1M13.8M79.6M8.50M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-184.0M-229.9M-184.2M-20.3M298.6M-166.7M-99.3M127.5M-17.8M-13.0M
Capital spending-41.0K-1.25M-2.38M-4.12M-3.25M-5.03M-15.3M-1.88M-801.0K-2.25M
Free cash flow-184.1M-231.2M-186.5M-24.4M295.3M-171.8M-114.6M125.6M-18.6M-15.2M
Cash from investing196.6M107.1M101.9M-159.0M-49.7M-105.1M-48.9M-224.1M-801.0K-2.25M
Cash from financing20.2M81.5M2.55M4.51M30.3M232.1M172.4M131.1M-15.0K-77.0K
Share buybacks30.3M7.51M-92.0K-1.90M-15.0K-77.0K
Change in cash32.8M-41.2M-79.7M-174.8M279.2M-39.7M24.2M34.5M-18.6M-15.3M

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 5, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeOct 26, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeOct 23, 2026Big-stake noticeSEC
424B5 · ProspectusOct 16, 2026Offer documentSEC
8-K · Current reportOct 16, 2026Material contractSEC
FWP · Free writing prospectusOct 16, 2026Offer documentSEC
4 · Change in ownershipOct 15, 2026Insider tradeSEC
4 · Change in ownershipOct 15, 2026Insider tradeSEC
4 · Change in ownershipOct 15, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportOct 14, 2026Management or board changeSEC
8-K · Current reportOct 5, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeSep 18, 2026Big-stake noticeSEC
4 · Change in ownershipSep 4, 2026Insider tradeSEC
4 · Change in ownershipSep 4, 2026Insider tradeSEC
4 · Change in ownershipSep 4, 2026Insider tradeSEC
144 · Notice of proposed saleSep 4, 2026Other filingsSEC
144 · Notice of proposed saleSep 2, 2026Other filingsSEC
144 · Notice of proposed saleSep 1, 2026Other filingsSEC
144 · Notice of proposed saleSep 1, 2026Other filingsSEC
144 · Notice of proposed saleSep 1, 2026Other filingsSEC
4 · Change in ownershipAug 21, 2026Insider tradeSEC
10-Q · Quarterly reportAug 6, 2026Quarterly reportSEC
8-K · Current reportAug 6, 2026ResultsSEC
4 · Change in ownershipJul 9, 2026Insider tradeSEC
8-K · Current reportJul 8, 2026Current reportSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
8-K · Current reportJun 17, 2026Meeting outcomeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
144 · Notice of proposed saleJun 3, 2026Other filingsSEC
144 · Notice of proposed saleJun 1, 2026Other filingsSEC
144 · Notice of proposed saleJun 1, 2026Other filingsSEC
144 · Notice of proposed saleJun 1, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2026Big-stake noticeSEC
8-K · Current reportMay 7, 2026Material contractSEC
424B5 · ProspectusMay 7, 2026Offer documentSEC
10-Q · Quarterly reportMay 7, 2026Quarterly reportSEC
8-K · Current reportMay 7, 2026ResultsSEC
EFFECT · Notice that a registration is effectiveMay 1, 2026Other filingsSEC
CORRESP · Letter to the SECApr 28, 2026Other filingsSEC
ARS · Annual report to shareholdersApr 28, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 28, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 28, 2026Meeting noticeSEC
SCHEDULE 13G · Big-stake noticeApr 27, 2026Big-stake noticeSEC
4 · Change in ownershipApr 17, 2026Insider tradeSEC
144 · Notice of proposed saleApr 16, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
UPLOAD · Letter from the SECMar 17, 2026Other filingsSEC
4 · Change in ownershipMar 13, 2026Insider tradeSEC
4 · Change in ownershipMar 13, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
S-3 · Registration statementMar 12, 2026Offer documentSEC
144 · Notice of proposed saleMar 10, 2026Other filingsSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
144 · Notice of proposed saleMar 3, 2026Other filingsSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 27, 2026Other filingsSEC
144 · Notice of proposed saleFeb 27, 2026Other filingsSEC
144 · Notice of proposed saleFeb 27, 2026Other filingsSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 26, 2026Other filingsSEC
S-8 · Registration statement for employee plansFeb 25, 2026Offer documentSEC
10-K · Annual reportFeb 25, 2026Annual reportSEC
8-K · Current reportFeb 25, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 6, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 30, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 21, 2026Big-stake noticeSEC
8-K · Current reportDec 12, 2025Management or board changeSEC
4 · Change in ownershipDec 8, 2025Insider tradeSEC
144 · Notice of proposed saleDec 5, 2025Other filingsSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
144 · Notice of proposed saleDec 1, 2025Other filingsSEC
144 · Notice of proposed saleDec 1, 2025Other filingsSEC
144 · Notice of proposed saleDec 1, 2025Other filingsSEC
144 · Notice of proposed saleDec 1, 2025Other filingsSEC
SCHEDULE 13G · Big-stake noticeNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2025Big-stake noticeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 7, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 6, 2025Quarterly reportSEC
8-K · Current reportNov 6, 2025ResultsSEC
8-K · Current reportOct 21, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 17, 2025Big-stake noticeSEC
4 · Change in ownershipSep 4, 2025Insider tradeSEC
4 · Change in ownershipSep 4, 2025Insider tradeSEC
4 · Change in ownershipSep 4, 2025Insider tradeSEC
4 · Change in ownershipSep 4, 2025Insider tradeSEC
144 · Notice of proposed saleAug 29, 2025Other filingsSEC
144 · Notice of proposed saleAug 29, 2025Other filingsSEC
144 · Notice of proposed saleAug 29, 2025Other filingsSEC
144 · Notice of proposed saleAug 29, 2025Other filingsSEC
4 · Change in ownershipAug 27, 2025Insider tradeSEC
144 · Notice of proposed saleAug 26, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
144 · Notice of proposed saleAug 8, 2025Other filingsSEC
10-Q · Quarterly reportAug 7, 2025Quarterly reportSEC
8-K · Current reportAug 7, 2025ResultsSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
3 · Initial statement of ownershipJun 30, 2025Insider tradeSEC
3 · Initial statement of ownershipJun 30, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
8-K · Current reportJun 13, 2025Management or board changeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 12, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
144 · Notice of proposed saleMay 30, 2025Other filingsSEC
144 · Notice of proposed saleMay 30, 2025Other filingsSEC
144 · Notice of proposed saleMay 30, 2025Other filingsSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
8-K · Current reportMay 8, 2025ResultsSEC
4 · Change in ownershipMay 2, 2025Insider tradeSEC
ARS · Annual report to shareholdersApr 25, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 24, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 24, 2025Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 17, 2025Big-stake noticeSEC
8-K · Current reportMar 28, 2025Management or board changeSEC
8-K · Current reportMar 10, 2025Current reportSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
144 · Notice of proposed saleFeb 28, 2025Other filingsSEC
144 · Notice of proposed saleFeb 28, 2025Other filingsSEC
144 · Notice of proposed saleFeb 28, 2025Other filingsSEC
144 · Notice of proposed saleFeb 28, 2025Other filingsSEC
S-8 · Registration statement for employee plansFeb 26, 2025Offer documentSEC
10-K · Annual reportFeb 26, 2025Annual reportSEC
8-K · Current reportFeb 26, 2025ResultsSEC
8-K · Current reportJan 10, 2025Current reportSEC
SC 13G · Big-stake noticeDec 6, 2024Big-stake noticeSEC
4 · Change in ownershipDec 3, 2024Insider tradeSEC
4 · Change in ownershipDec 3, 2024Insider tradeSEC
4 · Change in ownershipDec 3, 2024Insider tradeSEC
4 · Change in ownershipDec 3, 2024Insider tradeSEC
144 · Notice of proposed saleNov 29, 2024Other filingsSEC
144 · Notice of proposed saleNov 29, 2024Other filingsSEC
144 · Notice of proposed saleNov 29, 2024Other filingsSEC
144 · Notice of proposed saleNov 29, 2024Other filingsSEC
8-K · Current reportNov 25, 2024Current reportSEC
8-K · Current reportNov 14, 2024Material contractSEC
SC 13G/A · Big-stake notice, amendedNov 12, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 7, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 6, 2024Quarterly reportSEC
8-K · Current reportNov 6, 2024ResultsSEC
4 · Change in ownershipOct 10, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
4 · Change in ownershipSep 4, 2024Insider tradeSEC
144 · Notice of proposed saleAug 30, 2024Other filingsSEC
144 · Notice of proposed saleAug 30, 2024Other filingsSEC
144 · Notice of proposed saleAug 30, 2024Other filingsSEC
144 · Notice of proposed saleAug 30, 2024Other filingsSEC
4 · Change in ownershipAug 23, 2024Insider tradeSEC
144 · Notice of proposed saleAug 22, 2024Other filingsSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
144 · Notice of proposed saleAug 12, 2024Other filingsSEC
10-Q · Quarterly reportAug 7, 2024Quarterly reportSEC
8-K · Current reportAug 7, 2024ResultsSEC
4 · Change in ownershipJun 12, 2024Insider tradeSEC
4 · Change in ownershipJun 12, 2024Insider tradeSEC
4 · Change in ownershipJun 12, 2024Insider tradeSEC
4 · Change in ownershipJun 12, 2024Insider tradeSEC
4 · Change in ownershipJun 12, 2024Insider tradeSEC
4 · Change in ownershipJun 12, 2024Insider tradeSEC
8-K · Current reportJun 12, 2024Meeting outcomeSEC
4 · Change in ownershipJun 4, 2024Insider tradeSEC
4 · Change in ownershipJun 4, 2024Insider tradeSEC

This page holds 200 of 631 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Alector, Inc.’s releases · as of Oct 30, 2026

Common shares
148,877,074
Fully diluted
148,877,074

Fully diluted

LineSharesAs of
Common shares148,877,074Oct 30, 2026

Share count over time

CountShares
Oct 30, 2026148,877,074

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Bvf Inc10M6.7%US$18.6MSep 30, 2026
TCG Crossover Management, LLC10M6.7%US$18.5MSep 30, 2026
BlackRock7.7M5.2%US$14.2MSep 30, 2026
Vanguard7.42M5.0%US$13.7MSep 30, 2026
Acadian Asset Management LLC4.46M3.0%US$8.24MSep 30, 2026
Nantahala Capital Management, LLC4.32M2.9%US$7.99MSep 30, 2026
Kynam Capital Management, LP4.31M2.9%US$7.97MSep 30, 2026
Merck & Co., Inc.3.55M2.4%US$6.56MSep 30, 2026
Millennium3.05M2.0%US$5.63MSep 30, 2026
D. E. Shaw & Co., Inc.2.63M1.8%US$4.87MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
ADAR1 Capital Management, LLC2.51M1.7%US$4.65MSep 30, 2026
Geode Capital2.48M1.7%US$4.58MSep 30, 2026
683 Capital Management, LLC2.41M1.6%US$4.46MSep 30, 2026
Spruce Street Capital LP2.1M1.4%US$3.89MSep 30, 2026
Ikarian Capital, LLC1.98M1.3%US$3.67MSep 30, 2026
State Street1.83M1.2%US$3.38MSep 30, 2026
Medici Capital LLC1.65M1.1%US$3.06MSep 30, 2026
Mackenzie1.46M0.98%US$2.7MSep 30, 2026
Eversept Partners, LP1.42M0.95%US$2.62MSep 30, 2026
Jacobs Levy Equity Management, Inc1.39M0.93%US$2.57MSep 30, 2026
Euclidean Capital LLC1.31M0.88%US$2.42MSep 30, 2026
DWS1.07M0.72%US$1.98MSep 30, 2026
Deerfield Management Company, L.P.1.06M0.71%US$1.95MSep 30, 2026
Renaissance Technologies1.01M0.68%US$1.87MSep 30, 2026
Marshall Wace, LLP974K0.65%US$1.8MSep 30, 2026
Elmind Capital, LP916K0.62%US$1.69MSep 30, 2026
Panagora Asset Management Inc913K0.61%US$1.69MSep 30, 2026
DAFNA Capital Management LLC908K0.61%US$1.68MSep 30, 2026
Two Sigma898K0.60%US$1.66MSep 30, 2026
AQR Capital Management LLC894K0.60%US$1.65MSep 30, 2026
Schwab882K0.59%US$1.63MSep 30, 2026
Goldman Sachs792K0.53%US$1.46MSep 30, 2026
Northern Trust756K0.51%US$1.4MSep 30, 2026
Boothbay Fund Management, LLC533K0.36%US$986KSep 30, 2026
LMR Partners LLP450K0.30%US$833KSep 30, 2026
XTX Topco Ltd257K0.17%US$476KSep 30, 2026
Invesco256K0.17%US$474KSep 30, 2026
BNY252K0.17%US$466KSep 30, 2026
Balyasny Asset Management L.P.245K0.16%US$453KSep 30, 2026
Citadel231K0.16%US$427KSep 30, 2026
Bank of America222K0.15%US$410KSep 30, 2026
UBS194K0.13%US$359KSep 30, 2026
Nuveen191K0.13%US$354KSep 30, 2026
Ameriprise187K0.13%US$347KSep 30, 2026
Nano Cap New Millennium Growth Fund L P180K0.12%US$333KSep 30, 2026
Utah Retirement Systems175K0.12%US$323KSep 30, 2026
Strs Ohio140K0.09%US$259KSep 30, 2026
Morgan Stanley124K0.08%US$229KSep 30, 2026
Cantor Fitzgerald, L. P.120K0.08%US$222KSep 30, 2026
Bridgeway Capital Management, LLC115K0.08%US$213KSep 30, 2026

This page holds 50 of 131 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund2.84M1.9%US$5.7MJun 30, 2026
iShares Russell 2000 ETF2.55M1.7%US$5.12MJun 30, 2026
Select Biotechnology Portfolio1.38M0.93%US$2.98MMay 31, 2026
Fidelity Small Cap Index Fund1.07M0.72%US$1.61MJul 31, 2026
Vanguard Extended Market Index Fund1.03M0.69%US$2.08MJun 30, 2026
iShares Russell 2000 Growth ETF821K0.55%US$1.65MJun 30, 2026
Vanguard Explorer Fund673K0.45%US$1.02MJul 31, 2026
BlackRock Advantage Small Cap Core Fund635K0.43%US$1.37MMay 29, 2026
Vanguard Strategic Small-Cap Equity Fund629K0.42%US$1.26MJun 30, 2026
Small Company Growth Portfolio616K0.41%US$1.24MJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Fidelity Extended Market Index Fund484K0.33%US$1.05MMay 31, 2026
Vanguard Russell 2000 Index Fund469K0.31%US$1.01MMay 31, 2026
Schwab U.S. Small-Cap ETF442K0.30%US$954KMay 31, 2026
iShares Micro-Cap ETF330K0.22%US$664KJun 30, 2026
Schwab Small-Cap Index Fund239K0.16%US$361KJul 31, 2026
Vanguard Health Care Index Fund229K0.15%US$495KMay 31, 2026
Multi-Manager Small Cap Equity Strategies Fund229K0.15%US$494KMay 31, 2026
Master Small Cap Index Series196K0.13%US$394KJun 30, 2026
Fidelity Total Market Index Fund163K0.11%US$352KMay 31, 2026
iShares Russell 2000 Value ETF161K0.11%US$324KJun 30, 2026
Invesco RAFI US 1500 Small-Mid ETF155K0.10%US$234KJul 31, 2026
NVIT Multi-Manager Small Company Fund150K0.10%US$301KJun 30, 2026
Ultra-Small Company Market Fund143K0.10%US$286KJun 30, 2026
Fidelity Series Total Market Index Fund139K0.09%US$301KMay 31, 2026
Clearwater Select Equity Fund138K0.09%US$277KJun 30, 2026
NVIT Small Cap Value Fund133K0.09%US$268KJun 30, 2026
Nuveen Small Cap Blend Index Fund130K0.09%US$196KJul 31, 2026
EQ/2000 Managed Volatility Portfolio104K0.07%US$210KJun 30, 2026
Small Cap Equity Fund95,4090.06%US$192KJun 30, 2026
Schwab U.S. Broad Market ETF87,9570.06%US$190KMay 31, 2026
Fidelity Small Cap Growth Index Fund81,5990.05%US$164KJun 30, 2026
PACE Small/Medium Co Growth Equity Investments70,6370.05%US$107KJul 31, 2026
Vanguard Russell 2000 Value Index Fund64,1570.04%US$139KMay 31, 2026
Fidelity Nasdaq Composite Index Fund61,7810.04%US$133KMay 31, 2026
LVIP State Street Small-Cap Index Fund59,8890.04%US$120KJun 30, 2026
EQ/Small Company Index Portfolio57,5700.04%US$116KJun 30, 2026
Goldman Sachs Absolute Return Tracker Fund53,2020.04%US$107KJun 30, 2026
Vanguard Balanced Index Fund52,2710.04%US$105KJun 30, 2026
Small Cap Index Fund51,1200.03%US$103KJun 30, 2026
Schwab Total Stock Market Index Fund50,0000.03%US$75,500Jul 31, 2026
Vanguard Institutional Total Stock Market Index Fund47,6020.03%US$95,680Jun 30, 2026
Global X Russell 2000 ETF46,8820.03%US$70,792Jul 31, 2026
Fidelity ZERO Total Market Index Fund46,0020.03%US$69,463Jul 31, 2026
EQ/AB Small Cap Growth Portfolio44,8800.03%US$90,209Jun 30, 2026
Nuveen Equity Index Fund42,7520.03%US$64,556Jul 31, 2026
Bridge Builder Small/Mid Cap Value Fund39,9250.03%US$80,249Jun 30, 2026
Small Cap Index Fund39,5650.03%US$85,460May 31, 2026
Strategic Advisers U.S. Total Stock Fund38,5000.03%US$83,160May 31, 2026
Goldman Sachs Small Cap Growth Insights Fund38,1730.03%US$57,641Jul 31, 2026
MetLife Russell 2000 Index Portfolio33,6210.02%US$67,578Jun 30, 2026

This page holds 50 of 126 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Wong-Sarad Grace
Officer: Principal Accounting Officer
Sale3,625USD 2.51US$9,099Sep 4, 2026
Berkley Neil Lindsay
Officer: CFO & Chief Business Officer
Sale29,251USD 2.66US$77,808Sep 3, 2026
Rosenthal Arnon
Director, Officer: Chief Executive Officer
Sale72,606USD 2.66US$193KSep 3, 2026
Wong-Sarad Grace
Officer: Principal Accounting Officer
Sale5,165USD 2.67US$13,791Sep 3, 2026
Wong-Sarad Grace
Officer: Principal Accounting Officer
Sale656USD 2.75US$1,804Sep 2, 2026
Wong-Sarad Grace
Officer: Principal Accounting Officer
Sale3,475USD 1.88US$6,533Jun 3, 2026
Berkley Neil Lindsay
Officer: CFO & Chief Business Officer
Sale19,360USD 1.97US$38,139Jun 2, 2026
Wong-Sarad Grace
Officer: Principal Accounting Officer
Sale5,709USD 1.97US$11,247Jun 2, 2026
Rosenthal Arnon
Director, Officer: Chief Executive Officer
Sale87,216USD 1.97US$172KJun 2, 2026
Wong-Sarad Grace
Officer: Principal Accounting Officer
Sale1,820USD 2.65US$4,823Apr 16, 2026

Big stakes

StakeStakeSharesDateFiling
Chen Yu9.20%10MOct 22, 2025Schedule 13G
Deep Track Capital, LP8.61%12.8MOct 16, 2026Schedule 13G
BVF PARTNERS L P/IL8.40%9.37MSep 11, 2026Schedule 13G
Arnon Rosenthal7.40%8.21MDec 31, 2025Schedule 13G
BlackRock, Inc.5.20%5.78MMar 31, 2026Schedule 13G
Ra Capital Management, L.P.5.10%7.5MOct 19, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Louis J Lavigne Jr
Other companies: DocuSign, Inc. (Director · Apr 26, 2018 – Jun 17, 2019 · Past); NovoCure Limited (Director · Oct 1, 2015 – May 31, 2017 · Past); Zynga Inc (Director · Apr 23, 2015 – May 23, 2022 · Past); Depomed Inc (Director · Jul 6, 2013 – May 8, 2018 · Past); Accuray Incorporated (Director · Sep 4, 2009 – Nov 30, 2020 · Past); BMC Software Inc (Director · Aug 22, 2006 – Sep 10, 2013 · Past); Kyphon Inc (Director · Jul 31, 2006 – Nov 2, 2007 · Past); Arena Pharmaceuticals Inc (Director · Jul 28, 2006 – Jul 28, 2006 · Past); Equinix, Inc. (Director · Jun 8, 2006 – Jun 8, 2006 · Past)
Director · Since at least Feb 6, 2019
Terrance McGuire
Other companies: Tectonic Therapeutic, Inc. (Director · Since at least Jun 20, 2024); Invivyd, Inc. (Director · Since at least Aug 5, 2021); Seer, Inc. (Director · Since at least Dec 3, 2020); Cyclerion Therapeutics, Inc. (Director · Apr 1, 2019 – Nov 30, 2023 · Past); X4 Pharmaceuticals, Inc. (Director · Nov 15, 2017 – Jun 5, 2018 · Past); Pulmatrix, Inc. (Director · Jun 15, 2015 – May 16, 2019 · Past); Trevena, Inc. (Director · Jan 30, 2014 – May 14, 2014 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Mar 2, 2017 · Past); Ironwood Pharmaceuticals, Inc. (Director · Jun 3, 2013 – Apr 1, 2019 · Past)
Director · Feb 6, 2019 – Sep 11, 2023 · Past
Linda Rubinstein
Other companies: Nektar Therapeutics (Chief Financial Officer · Since at least May 15, 2026); Adverum Biotechnologies Inc (CHIEF FINANCIAL OFFICER · Since at least Dec 12, 2022); Five Prime Therapeutics Inc (Interim CFO · Apr 13, 2018 – Apr 13, 2018 · Past); Solexa Inc (VP and CFO · Feb 2, 2006 – Jan 26, 2007 · Past)
Interim Chief Financial Ofcr · Sep 8, 2021 – Sep 8, 2021 · Past
Elizabeth Garofalo
Other companies: Xenon Pharmaceuticals Inc. (Director · Since at least Jun 3, 2021); ACADIA Pharmaceuticals Inc. (Director · Since at least Sep 29, 2020); Exicure, Inc. (Director · Mar 5, 2021 – Jun 13, 2022 · Past)
Board Member · Since at least Sep 23, 2021
Shehnaaz Suliman
Other companies: 10x Genomics, Inc. (Member · Since at least Sep 11, 2019); Ultragenyx Pharmaceutical Inc. (Director · Since at least Jan 30, 2019); Theravance Biopharma, Inc. (SVP, Corp Dev & Strategy · Aug 1, 2017 – Feb 20, 2019 · Past)
President and COO · Dec 9, 2019 – Dec 10, 2021 · Past
Dave Wehner
Other companies: Aurora Innovation, Inc. (Director · Since at least Feb 27, 2026); Meta Platforms, Inc. (Chief Financial Officer · Apr 24, 2019 – Aug 15, 2022 · Past)
Director · May 10, 2019 – Jun 12, 2024 · Past
Errol B Desouza
Other companies: Royalty Pharma plc (Director · Jun 7, 2024 – May 13, 2025 · Past); Cyclerion Therapeutics, Inc. (Director · Nov 30, 2023 – Nov 30, 2023 · Past)
Director · Since at least Mar 19, 2024
Marc Grasso
Other companies: Kyverna Therapeutics, Inc. (Chief Financial Officer · Since at least Jun 30, 2025); Kura Oncology, Inc. (CFO, CBO · Aug 21, 2018 – Jan 26, 2022 · Past)
Chief Financial Officer · Since at least Feb 7, 2022
Mark Altmeyer
Other companies: Myovant Sciences Ltd (Director · Oct 26, 2016 – Aug 31, 2018 · Past); Sio Gene Therapies Inc (Pres (ASG) & Chief Comm. Ofc. · Jun 10, 2015 – Mar 15, 2018 · Past)
Board Member · Since at least Mar 19, 2024
Tillman U Gerngross
Other companies: Invivyd, Inc. (Chief Executive Officer, Director · Aug 5, 2021 – Jan 30, 2022 · Past); X4 Pharmaceuticals, Inc. (Director · Nov 15, 2017 – Jun 5, 2018 · Past)
Director · Feb 6, 2019 – Jun 14, 2023 · Past
All 26 people
PersonSeat
Sara Kenkare-Mitra
Other companies: Unicycive Therapeutics, Inc. (Director · Since at least Jul 28, 2025)
President and Head of R&D · Since at least Jun 2, 2025
Arnon RosenthalChief Executive Officer, Director · Since at least Jun 2, 2026
Caiyan LiHead of Clinical Development & Data Science · Since at least Nov 4, 2026
Calvin YuVice President, Finance · Feb 6, 2019 – Jul 2, 2021 · Past
Clare HuntChief People and Places Officer · Since at least Nov 4, 2026
Danielle PasqualoneGeneral Counsel · Since at least Nov 4, 2026
Errol De SouzaBoard Member · Since at least Nov 5, 2026
Gary RomanoChief Medical Officer · Oct 1, 2023 – Mar 3, 2025 · Past
Grace Wong-SaradPrincipal Accounting Officer · Since at least Jun 20, 2025
Hua LongSenior Vice President and Head of Research · Since at least Nov 4, 2026
Kristine YaffeDirector · Since at least Jun 17, 2021
Neil BerkleyChief Financial Officer and Chief Business Officer · Since at least Jun 20, 2025
Paula HammondBoard Member · Since at least Mar 20, 2020
Richard H. SchellerBoard Member · Since at least Jun 17, 2026
Robert KingChief Development Officer · Feb 6, 2019 – Oct 1, 2022 · Past
Robert PaulChief Medical Officer · Feb 6, 2019 – Aug 9, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about Alector, Inc.